Lumentum’s drop reads like profit-taking, not a broken growth story. The cleanest reason is simple: the stock sold off only weeks after the company posted record quarterly revenue of $808.4 million, up 90.1% year over year, while non-GAAP gross margin jumped to 47.9% from 42.5% in the prior quarter. That is not what an earnings inflection rolling over looks like. It looks like a market taking some air out of a name that had already surged 133.2% year to date.
The fundamental setup still leans bullish. Lumentum is not being carried by vague AI hopes alone; it is printing real acceleration, with revenue growth at 21.0% on a trailing basis and EPS growth of 104.7% year over year, while the latest quarter came in ahead of consensus at $2.37 versus a $2.27 estimate. That matters because this is now a six-beat-in-seven-quarter earnings story, not a one-quarter wonder, and management is still pointing to more earnings power as co-packaged optics and optical circuit switches ramp.
The balance sheet also got meaningfully stronger at the same time the market was repricing the stock. Cash, cash equivalents, and short-term investments climbed to $3.17 billion in the latest quarter, up $2.02 billion sequentially. For a high-beta hardware name, that undercuts the easy bear narrative that any pullback must be signaling financial stress. It also helps explain why Lumentum scores a strong 80 on Financial Health and 95 on Growth within the TickerSpark Score, even though the valuation sub-score sits at a much weaker 33.
The tape itself supports the idea that this is consolidation after a huge move, not a trend break. LITE remains above both its 50-day moving average of $880.76 and its 200-day moving average of $474.47, even after the latest drop, and its RSI has cooled to 49.07 from overbought territory. Add in Nasdaq-100 inclusion effective May 18 and the setup starts to look familiar: strong earnings, index-driven inflows, a violent rerating, then a reset. Against that backdrop, today’s weakness looks more like digestion than damage.
The valuation case against Lumentum is real, and it is the one argument bulls cannot wave away. At 146.44 times trailing earnings, 28.17 times sales, and 131.63 times EV/EBITDA, the stock is priced for near-flawless execution. Compared with peers like Fabrinet at 58.53 times earnings and 5.81 times sales, Lumentum is carrying a far richer multiple, so any wobble can trigger sharp multiple compression even if the business keeps executing.
The insider tape is not ideal either. Recent filings show five sales totaling 16,769 shares and $15.20 million, with no open-market buys in the same stretch. That does not kill the thesis, but it reinforces the idea that this is a stock that had become crowded and expensive enough to invite profit-taking. We still think that is the right interpretation of the move, because the operating numbers remain too strong to call this a broken story.
That keeps us in the buy-the-reset camp, not the run-for-cover camp. We would respect the volatility because the ATR is $82.41 and this is clearly not a low-drama stock, but the bigger trend stays intact as long as LITE holds around its 50-day moving average and keeps pairing revenue growth with margin expansion. A stock sitting above its 50-day and 200-day averages with a Momentum component of 100 in the TickerSpark Score is not flashing structural breakdown.
What would change our mind is straightforward: a quarter where AI-driven growth slows materially, margins give back the recent improvement, or the stock loses that intermediate trend support decisively. Until then, this looks like a reversal setup inside an intact uptrend, and we would treat the latest drop as valuation air coming out after a huge rerating rather than evidence the AI optics thesis has stalled.
